The outcome after living donor liver transplantation (LDLT) using grafts with multiple bile ducts (BDs) remains unclear. We analyzed 510 patients who received an adult-to-adult right lobe LDLT between 2000 and 2015 and compared outcome parameters of those receiving grafts with 2 BDs (n = 169) with patients receiving grafts with 1 BD (n = 320). Additionally, patients receiving a graft with 3 BDs (n = 21) were analyzed. Demographic variables and disease severity were similar between the groups. Roux-en-Y reconstruction was significantly more common in the 2 BD group (77% versus 38%; P < 0.001) compared with the 1 BD group. No difference was found in biliary complication rates within 1 year after LDLT (1 BD versus 2 BD groups, 18% versus 21%, respectively; P = 0.46). In the 2 BD group, 82/169 (48.5%) patients were reconstructed with 2 anastomoses. The number of anastomoses did not negatively impact biliary complication rates. Recipients' major complication rate (Clavien ≥ 3b) was similar between both groups (1 BD versus 2 BD groups, 21% versus 24%, respectively; P = 0.36). Furthermore, no difference could be found between the 1 BD, the 2 BD, and the 3 BD groups in the frequency of developing biliary complications within 1 year (18%, 21%, 14%, respectively; P = 0.64), BD strictures (15%, 15%, 5%, respectively; P = 0.42), or BD leaks (10%, 11%, 10%, respectively; P = 0.98). In addition, the 1-year (90% versus 91%), 5-year (82% versus 77%), and 10-year (70% versus 66%) graft survival rates as well as the 1-year (92% versus 93%), 5-year (84% versus 80%), and 10-year (75% versus 76%) patient survival rates were comparable between the 1 BD and the 2 BD groups (P = 0.41 and P = 0.54, respectively). In conclusion, this study demonstrates that selected living donor grafts with 2 BDs can be used safely without negatively impacting biliary complication rates and graft or patient survival rates.
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ranging from 15% to 60%. (7) (8) (9) (10) Biliary complications include biliary strictures as well as BD leakage at the side of the anastomosis or cut surface. (11) So far, it remains unclear whether using a living donor (LD) graft with multiple BDs increases the risk for the development of postoperative anastomotic biliary complications or even graft loss. Although some groups reported an increased complication rate using LD grafts with multiple BDs, (12) others did not find an association between the development of biliary strictures and the number of BDs. (13) This high-volume, single-center study was designed to determine if the number of BDs reconstructed during LDLT impacts posttransplant outcome. The outcomes of patients receiving a LD graft with 2 BDs were compared with the outcomes of patients receiving a graft with only 1 BD. Additionally, the outcomes of patients receiving a graft with 3 BDs were analyzed and compared.
Patients and Methods

sTUDY pOpULATION
All patients receiving adult-to-adult LDLTs with right lobe liver grafts between April 2000 and May 2015 at our institution were included in the study. The study was approved by the ethics commitee of the University Health Network, Toronto General Hospital. Recipient data, including sex, age, underlying liver disease, body mass index (BMI), Model for End-Stage Liver Disease (MELD) score, and wait-list time, were collected prospectively. In addition, donor outcome parameters were documented. Recipient as well as donor outcome parameters were analyzed and compared between patients who received a LD graft with 2 BDs, 3 BDs, and all patients receiving a graft with only 1 BD during the same time period.
All anatomically suitable patients listed for deceased donor liver transplantation (DDLT) at the University of Toronto are offered the option of living donation regardless of their MELD score. All living donations are voluntary and altruistic, and both donors and recipients are informed of the complication and survival rates at our institution. (1, 14) 
DONOR AssEssmENT
Donors who are selected for living donation at our program have to be in good health and fulfill certain criteria. This includes the following: 18-60 years of age, no underlying medical conditions or comorbidities, and no underlying liver disease or abnormal liver tests or vascular and biliary anomalies. In addition, donors must have a sufficient remnant liver volume (≥30%) and provide a graft with an adequate graft-to-recipient weight ratio (GRWR). Only donors who are ABO compatible with the recipients are selected. Currently, steatosis of >10% is a contraindication for living donation at our program. At first, potential donors have to complete a screening health questionnaire as well as various blood tests, viral serology, imaging, and consultations with health care professionals from medicine and psychiatry who are independent of the transplant program. Furthermore, to evaluate graft and donor remnant liver volumes and the vascular anatomy, all potential donors undergo triphasic computed tomography as well as magnetic resonance cholangiography (MRCP) for an evaluation of the biliary anatomy. (15) The aim is to achieve a GRWR of 0.8% or more and a residual liver volume in the donor of 30% or more. During donor surgery, at least 3 intraoperative cholangiographies are performed to identify the correct site of BD transection and to assess for any bile leaks or stenoses after closure of the right BD stump. Our donor surgical procedures have been published previously. (16) 
DONOR AND GRAFT DATA AND sURGICAL TECHNIQUE
The data collected and analyzed from donors and grafts included sex, age, BMI, cold ischemia time (CIT), and warm ischemia time (WIT). Additionally, the number of BDs and the type of BD reconstruction were documented. Duct-to-duct (DD) anastomosis with continuous sutures was the preferred method for biliary reconstruction when technically possible. Patients with primary sclerosing cholangitis (PSC), size mismatch of the biliary orifice, or where the anastomosis would have been under tension received a bilioenteric anastomosis. When 2 BDs were in close proximity, 6-0 polydioxanone sutures were used to perform the ductoplasty and create a single orifice for anastomosis. Stents were only used in a few selected cases after BD reconstruction in the earlier period of this series (n = 5). The biliary reconstruction was performed without microscope by the transplant surgeon performing the whole transplant procedure. The same surgical team, which consisted of 4 surgeons, performed all the procedures during the study period. The BD anastomosis was performed with interrupted or continuous sutures; cholangiography in the recipient was not regularly performed after BD reconstruction. In case a ductoplasty could not be performed or there was a size mismatch, the BDs were reconstructed with Roux-en-Y reconstruction. In selected cases, some patients received both: a DD anastomosis and a Roux-en-Y reconstruction. (13) The dissection of the donor BD was performed with great caution to avoid damaging the peritoneal sheet of the BD. The transection point for the recipient BD was chosen as close to the parenchyma as possible. Whether the middle hepatic vein was taken along with the graft was documented for comparison between groups. The postoperative follow-up of LDs was conducted at months 1, 3, and 6 after surgery and annually thereafter at the Living Donor Liver Transplant Clinic and included laboratory investigations and magnetic resonance imaging after the third month.
pOsTTRANspLANT OUTCOmEs
The course of posttransplant values at day 7, after 3 months, 6 months, and 1 year of international normalized ratio (INR), bilirubin, aspartate aminotransferase (AST), alanine aminotransferase (ALT), and alkaline phosphatase were analyzed as markers of liver function and reperfusion injury. The 30-day complication and mortality rates were recorded. Postoperative complications were graded according to the DindoClavien classification (17) and patients with major complications defined as Dindo-Clavien ≥ 3b. Episodes of acute cellular rejection during the first year were identified. BD complications (including biliary leak and biliary stricture) were documented throughout the entire follow-up period and analyzed and compared between both groups. To diagnose biliary leaks, ultrasound, computed tomography, and/or magnetic resonance imaging were performed. Similarly, for the diagnosis of biliary strictures, endoscopic retrograde cholangiopancreatography (ERCP), percutaneous transhepatic cholangiography (PTC), and/or MRCP were performed. Biliary complications were divided into 2 groups: those with early onset (<1 year) and those with late onset (≥1 year). Treatment of biliary complications included ERCP with stenting, PTC with drainage, and surgery with BD reconstruction. Type, time of onset, and treatment of biliary complications have been compared between recipients of a graft with 1 BD versus 2 BDs. Furthermore, recurrence of HCC or hepatitis C virus (HCV) was monitored in adherence to previously described standard protocols. (18, 19) , and rejection) on the development of biliary complications. All tests were 2-tailed, and a P value of <0.05 was considered statistically significant.
Results
From 2000 to 2015, 510 patients received a right lobe LDLT at the Multi-Organ Transplant Program of the Toronto General Hospital, University of Toronto. From those, 169 (33%) patients received a LD graft with 2 BDs (2 BD group) and were compared with 320 (63%) patients receiving a LD graft with only 1 BD (1 BD group). Additionally, 21 patients received a graft with 3 BDs. The median follow-up time was similar in both groups (P = 0.66), with 70 months (range, 0.1-178 months) in the group with 2 BDs and 61 months (range, 0-184 months) in the 1 BD group.
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RECIpIENTs' CHARACTERIsTICs
Demographic variables including age, sex, and BMI were comparable between recipients receiving a graft with 2 BDs and those receiving a 1 BD graft ( Table 1) . The mean age at transplantation was 53 years in patients who received a 1 BD graft, and 51 years in patients who received a graft with 2 BDs. Preoperative laboratory parameters (INR, creatinine, and MELD) were similar in both groups, except for a higher preoperative bilirubin in patients receiving a graft with 2 BDs (88 ± 126 µmol/L versus 103 ± 163 µmol/L; P = 0.04; Table 1 ). There was no difference in the number of patients with HCV, HCC, fulminant hepatic failure (FHF), or PSC between the groups, and both groups had comparable time on the waiting list (Table 1) .
DONOR AND GRAFT CHARACTERIsTICs
Donor age, sex, and BMI were comparable between the 1 BD group and the 2 BD group (Table 2) . Furthermore, there was no difference in CIT and WIT as well as the number of grafts with middle hepatic vein or GRWR <0.8% ( Table 2) . As expected, Roux-en-Y reconstruction of the BD was significantly more common in the 2 BD group (1 BD versus 2 BD, 123 [38.4%] versus 130 [76.9%] patients; P < 0.001; Table 2 ). In total, 411 (80.7%) patients were reconstructed with 1 anastomosis, 90 (17.7%) with 2 anastomoses, and 8 (1.6%) patients with 3 anastomoses. From all patients with ≥2 BDs (n = 190), 92 (48.4%) received 1 anastomosis, 90 (47.4%) received 2 anastomoses, and 8 (4.2%) received 3 anastomoses. In the entire series, 9 patients had BD reconstruction with both DD and Roux-en-Y anastomosis. An exact description of biliary reconstruction is summarized in Supporting Table 1 . Patients with 2 BDs received significantly more often antibody induction therapy (86% versus 76%; P = 0.01). There was no difference regarding the type of induction therapy, such as simulect versus thymoglobulin, or baseline immunosuppression with tacrolimus, cyclosporine, or mycophenolate (Table 2) .
pOsTOpERATIvE OUTCOmE AFTER LDLT
The immediate postoperative outcome, assessed by peak levels of AST, ALT, and INR as well as the decrease of INR and bilirubin over the first 7 postoperative days, was similar between both groups (Table 3) . Furthermore, liver injury and liver function at day 7, evaluated by AST, ALT, INR, alkaline phosphatase, and bilirubin, were similar between both groups, except for a slightly higher INR in the 2 BD group (P = 0.047; Table 3 ). Alkaline phosphatase and NOTE: Data are given as n (%), mean ± SD, or median (range). NOTE: Data are given as n (%) or mean ± SD.
bilirubin levels at 1 year after transplantation were comparable between both groups ( Table 3 ). The proportion of recipients with major complications (Clavien ≥3b) was similar between both groups (1 BD versus 2 BDs, 21% versus 24%; P = 0.36), and both groups had a comparable frequency of retransplantations (1 BD versus 2 BDs, 18 [6%] versus 9 [5%]; P >0.99; Table 4 ).
pOsTOpERATIvE pATIENT AND GRAFT sURvIvAL
The 1-year (90% versus 91%), 5-year (82% versus 77%), and 10-year (70% versus 66%) graft survival was similar between the 1 BD and the 2 BD groups (P = 0.41; Table 4 ; Fig. 1A ). Likewise, there was no significant difference in the 1-year, 5-year, and 10-year patient survival (1 BD versus 2 BDs, 92%, 84%, 75% versus 93%, 80%, 76%, respectively; P = 0.54; Table 4 ; Fig. 1B ). In addition, patients receiving a graft with 3 BDs (n = 21) had a comparable 1-, 5-, and 10-year graft survival to those with ≤2 BDs (n = 492; ≤2 BDs versus 3 BDs, 90%, 80%, 60% versus 94%, 87%, 75%, respectively; P = 0.75). There was no difference in graft survival between patients with 1 anastomosis to those who received ≥2 anastomoses (P = 0.56). Furthermore, the number of anastomoses in patients who received a graft with ≥2 BDs (n 
BILIARY COmpLICATIONs AFTER LDLT
The overall proportion of patients with biliary complications after LDLT was not different between both groups (1 BD versus 
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with DD reconstruction (n = 9/30), 23.1%; and 2 BDs with Roux-en-Y reconstruction or combined (n = 31/99), 23.8%, respectively (P >0.99). Similarly, there was no difference between the 4 groups in the number of patients who developed biliary complications within 1 year after transplantation (P = 0.68) or biliary strictures (P = 0.66) and biliary leaks (P = 0.59).
In both the 1 BD and the 2 BD groups, most biliary complications occurred within the first postoperative year, with no significant difference in the time to biliary complications (estimated proportion of patients with biliary complication after 1 year: 1 BD, 18% and 2 BDs, 21%; P = 0.98; Fig. 2A ). When only patients who developed biliary complications were considered and graft survival was compared between the 1 BD group and the 2 BD group, there was a trend toward poorer graft survival in those patients who developed biliary complications and had received a graft with 2 BDs (patients with biliary complications, n = 115; 1-, 5-, and 10-year graft survival for 1 BD versus 2 BDs; 96%, 90%, 78% versus 92%, 77%, 64%, respectively; P = 0.15; Fig. 2B ). In the 1 BD group, 10 patients (3%) developed HAT, and from those, 2 patients developed biliary complications. In the 2 BD group, 8 patients developed HAT (5%), with 4 patients additionally developing biliary complications. There was no difference between the 2 groups (P = 0.18; Table 5 ).
In total, 51 (10%) patients developed a biliary leak. Of those, 33 (10%) patients had received a LD graft with 1 BD, and 18 (10.7%) patients had received a LD graft with 2 BDs (P >0.99; Table 5 ). From those patients who developed a biliary leak (n = 51), the 2 BD group NOTE: Data are given as n (%).
(n = 18) showed significantly worse graft survival when compared with the 1 BD group (n = 33; 1-, 5-, and 10-year graft survival for 1 BD versus 2 BD groups; 94%, 90%, 90% versus 82%, 71%, 71%, respectively; P = 0.03). Similarly, the patient survival rate was significantly lower in patients with bile leak in the 2 BD group (1-, 5-, and 10-year patient survival for 1 BD versus 2 BDs: 100%, 96%, 96% versus 82%, 71%, 71%; P = 0.002). Furthermore, the combination of a graft with 2 BDs and the development of a bile leak resulted in a significantly worse graft survival in a time- ; P = 0.456). From the patients who died in the BD leak group (n = 7), 6 patients died in the 2 BD group (multiorgan failure or sepsis, n = 2; cancer, n = 4), and 1 patient died in the 1 BD group (multiorgan failure, n = 1). Notably, there were more patients transplanted because of HCC in the 2 BD group with biliary leak than in the 1 BD group with biliary leak (56% [10/18] versus 18% [6/33] ; P = 0.01). Biliary strictures occurred in 48 (15%) patients in the 1 BD group and in 26 (15%) patients in the 2 BD group (P = 0.89; Table 5 ). Comparing graft survival in patients who developed a biliary stricture with 2 BDs to the group receiving a graft with 1 BD did not reveal any difference in univariate analysis (1-, 5-, and 10-year graft survival for 1 BD versus 2 BDs; 98%, 91%, 73% versus 100%, 84%, 66%; P = 0.94) and in the time-dependent Cox regression model (HR, 0.74; 95% CI, 0.255-2.139; P = 0.576). Furthermore, in the subgroup of patients who developed biliary strictures, there was no difference in patient survival comparing the 1 BD and the 2 BD groups (1-, 5-, and 10-year graft survival for 1 BD versus 2 BD: 100%, 93%, 81% versus 100%, 88%, 84%, respectively; P = 0.94). Treatment of patients with biliary strictures was comparable between the 2 BD and the 1 BD groups (Table 5) .
When comparing patients who received a LD graft with 1 BD, 2 BDs, or 3 BDs, no difference could be found in the frequency of developing biliary complications within 1 year (18%, 21%, 14%, respectively; P = 0.64), BD strictures (15%, 15%, 5%, respectively; P = 0.42), or BD leaks (10%, 11%, 10%, respectively; P = 0.98; Fig. 3 ). Furthermore, in the subgroup of patients who were only reconstructed with a DD anastomosis (1 BD versus 2 BD groups; 197 versus 39), there was LIvER TRANspLANTATION, vol. 24, No. 11, 2018 KOLLmANN ET AL.
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no difference in the development of biliary complications within 1 year (19% versus 20%; P = 0.83), BD strictures (13% versus 13%, P = 0.36), or BD leaks (10% versus 5%; P = 0.54). Various clinically relevant factors, including donor and recipient-specific factors, were analyzed for their impact on biliary complications in univariate and multivariate Cox regression analysis (Table 6) . Patients who developed posttransplant rejection showed an increased risk in developing biliary complications in a multivariate analysis (HR, 1.82; 95% CI, 1.24-2.68; P = 0.002; Table 6 ). The risk for the development of biliary complications was not influenced by patient or donor sex and age or by PSC as primary indication, number of BD, or BD reconstruction technique (Roux-en-Y reconstruction versus DD; Table 6 ).
DONOR pOsTOpERATIvE OUTCOmE
All LDs survived the surgery and could return to their routine activities. There was no difference in regard to donor postoperative complication rates between both groups (1 BD versus multiple BDs; 25% versus 24%; P = 0.83). The major complication rate (Clavien ≥ 3b) was also not different between both groups of donors (1 BD versus multiple BDs: 5% versus 6%; P = 0.68). Furthermore, there was no difference in the duration of the hospital stay after hepatectomy (6.8 days versus 6.5 days; P = 0.49).
Discussion
To date, only a few studies analyzing the impact of using grafts with multiple BDs on patient outcome after LDLT have been performed. By including 510 patients with adult-to-adult right lobe LDLT transplanted at a single high-volume center in North America, we determined that LDLT using grafts with 2 BDs in selected patients is safe and does not negatively impact patient outcomes.
It is well known that the incidence of anastomotic biliary complications is higher in patients receiving LDLT compared with those with DDLT. (20) The main reason for this is the technical challenge of BD reconstruction during LDLT, which is attributed to the small and/or multiple BDs that are additionally jeopardized by poor blood supply of both donor and recipient BD. (21) In a recently published study from the Adult-to-Adult Living Donor Liver Transplantation Cohort Study, biliary leaks and biliary strictures have been reported to be more common after LDLT when compared with DDLT (P <0.001 and P <0.001, respectively) as were biliary tree infections, HAT, and blood infections. (22) Various technical improvements of BD reconstruction techniques have therefore been evaluated and reported. (10, 23, 24) Samstein et al. reported that 72%-73% of biliary strictures are resolved within 1 year. (22) However, it is still not clear whether patients who receive LD grafts with 2 BDs are at higher risk of postoperative biliary complications or poor graft survival. From the 510 patients included in this study, 169 (33%) patients received a LD graft with 2 BDs, and 21 (4%) patients received a graft with 3 BDs. Patient outcomes of the 2 BD group, including biliary complications, were not different from the group receiving 1 BD graft. This study identified no difference in the frequency of developing biliary complications comparing the 1 BD with the 2 BD group (23% versus 24%; P = 1). A previous study performed at our institution analyzing 344 patients with LDLT reported the incidence of biliary strictures in 19.5% of patients and biliary leaks in 14.5%. (13) The current study shows an improvement in this complication rate with a decrease in biliary strictures (1 BD and 2 BDs; 15% and 15%) and biliary leaks (1 BD and 2 BDs: 10% and 11%). In addition, we determined that both groups display a similar frequency of biliary complications. This stands in contrast to the previous data published 10 years ago, which showed a higher biliary complication rate in the group with multiple BDs (17% versus 46%; P = 0.02). (25) The progress in this field might be explained by an improvement of the surgical technique, which includes special attention to the transection of the BD during donor surgery in order to protect the blood supply of the BD. (26) Moreover, the increasing number of ductoplasties and, therefore, DD reconstructions could have contributed to the favorable outcome.
Although Roux-en-Y reconstruction has been the standard technique at the beginning of LDLT, DD anastomosis has become more frequent over time due to a shorter operation time, a more physiologic enteric function, and the option for endoscopic access to the biliary tract when needed. (27) (28) (29) It is not clear yet which reconstruction technique is superior for LDLT. (4) In a large analysis published in 2006, Kasahara et al. evaluated the outcome of 321 patients who received right lobe LDLT and compared biliary complication rates between those receiving DD anastomosis versus Rouxen-Y reconstruction. (30) The authors reported an overall biliary complication rate of 24% with a significantly higher biliary stricture rate in patients with DD anastomosis versus Roux-en-Y (26.6% versus 4.7%, respectively). (30) In our cohort, patients who received grafts with 2 BDs received Roux-en-Y reconstruction significantly more often. The type of reconstruction, Rouxen-Y versus DD, did not influence patient outcomes or graft survival. Lin et al. reported a reduction of biliary complications after LDLT after the implementation of the use of microsurgical biliary reconstruction. (31) The authors used an operating microscope, and the biliary anastomoses in the reported 577 consecutive LDLTs were performed by a single microsurgeon. (31) With this approach, Lin et al. could reduce the biliary complication rate to 6.79%. (31) On the other side, Miyagi et al. (32) recently reported that the different BD reconstruction methods (Roux-en-Y reconstruction versus DD) as well as the reconstruction technique (with or without microsurgery) did not impact the development of BD stricture or BD leak. (32) Our results support the observation that the number or type of BD anastomoses does not impact postoperative outcome. In our series, significantly worse graft survival was observed in patients who had received a LD graft with 2 BDs and additionally had developed a bile leak. This finding suggests that biliary complications in those patients with 2 BDs are more difficult to treat. Treatment options of biliary complications after LDLT primarily include endoscopic and percutaneous interventions, (33) which are more challenging in the presence of multiple BDs. The success rate remains variable, and therefore, patients often require multiple interventions or even surgery. (25, (34) (35) (36) In our cohort, there was no difference in the treatment modalities comparing the 1 BD group to the 2 BD group in the subgroup of patients who developed a BD leak. Furthermore, when comparing the survival rates in the 2 groups, we found that more patients died from biliary complications in the 1 BD group.
Our study has several limitations, including the retrospective study design as well as the lack of information on the distance between the BDs in the multiple BDs group. Furthermore, we were not able to address 2 previously reported risk factors in LDLT for the development of biliary complications: the size of the BD (<4 mm) (37) and the anatomy of the right posterior BD. (38) Nevertheless, we believe that the strength of this study lies in a well-defined patient population from 1 single center with standardized criteria for donor selection. All patients were followed prospectively in our database without loss of follow-up. Furthermore, all patients received well-defined and uniform surgical as well as medical pretransplant and posttransplant treatment.
In summary, we demonstrated that using LD grafts with 2 BDs is safe and does not negatively impact the biliary complication rate. Moreover, overall graft and patient survival was not different in patients with 2 BDs compared with those with 1 BD.
